Tracked deals
6
6 tracked deals across 2018-2025.
Waltham, Massachusetts, United States
Trinity is the commercialization intelligence partner for life sciences, powering the commercialization journey by blending deep therapeutic expertise and a purpose-built technology platform to accelerate clarity and confidence—from pre-launch through scale to loss of exclusivity.
Tracked deals
6
6 tracked deals across 2018-2025.
Recent pace
1
1 tracked deal announced in the last 12 months.
Deal mix
Buyout
4 buyout · 1 addon · 1 divestiture
Last 6 years
Supporting Data
Trinity Life Sciences has acquired EVERSANA’s advisory services operation across Asia-Pacific and the Middle East (APACME), bringing regional teams in Singapore, Tokyo, Mumbai, Shanghai, Sydney and Dubai into Trinity’s global footprint. The transaction deepens Trinity’s local life‑sciences commercialization capabilities while EVERSANA will continue to operate its broader commercialization services and maintain a strategic collaboration with Trinity for shared clients.
Trinity Life Sciences has acquired Illinois-headquartered D Cube Analytics to expand its data science, AI/ML and digital transformation capabilities for life sciences commercialization. The deal brings D Cube's suite of analytics platforms and more than 250 employees (including offices in Bengaluru and Chennai) into Trinity's commercialization portfolio to accelerate analytics-driven commercial decision-making.
Trinity Life Sciences has acquired New York–headquartered CBPartners to significantly scale its Value, Access and Pricing business, adding over 75 dedicated experts and expanding Trinity's presence in New York City, San Francisco and London. The acquisition augments Trinity's market access, pricing and commercial strategy capabilities to better support life sciences companies in bringing products to market and ensuring patient access globally.
Trinity Life Sciences acquired New Jersey-based BluePrint Research Group to strengthen its commercial strategy, insights and analytics capabilities for the life sciences industry and expand its international footprint, including a London office. The deal integrates BluePrint's team into Trinity's global platform and adds resources across India and the U.S. coasts.
TRINITY, a Parthenon Capital Partners–backed life sciences commercialization solutions provider, acquired Bell Canyon Consulting to enhance its Commercial Data Solutions suite by adding master data management, data warehousing and analytics capabilities. The acquisition is an add-on to TRINITY’s life sciences offering to expand technical capabilities and provide an end-to-end commercial data solution for emerging life sciences companies.
Trinity Partners has acquired TGaS Advisors, a benchmarking and advisory firm serving commercial organizations in the life sciences industry. TGaS will operate as a wholly‑owned division of Trinity, adding benchmarking, vendor insights and comparative intelligence to Trinity’s commercialization, real‑world evidence and market research capabilities.
Turn tracked acquisition activity into an outreach-ready buyer list.